Transarterielle Chemoembolisation (TACE)

Die transarterielle Chemoembolisation (TACE) ist beim hepatozellulären Karzinom (HCC) im Stadium BCLC B Therapie der Wahl. Das Verfahren macht sich zunutze, dass das HCC überwiegend von kleinen arteriellen Gefäßen durchblutet wird. Mit Hilfe von Angiographiekathetern können interventionelle Radiologen diese Gefäßgebiete aufsuchen, um den Tumor gezielt zu behandeln.

Abstract

Transarterial Chemoembolization (TACE) is the standard procedure for intermediate stage hepatocellular carcinoma (HCC). TACE combines local chemotherapy with embolization of the arterially hypervascularisated HCC. In this article we present indication, contraindication, technical background, practical approach and side effect of TACE.

Schlüsselwörter

HCC - Leberzellkarzinom - Transarterielle Chemoembolisation - TACE

Keywords

HCC - hepatocellular carcinoma - transarterial chemoembolization - TACE

• Literatur

• 1 Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002; 359: 1734-1739
• 2 Lencioni R, Aliberti C, de Baere T et al. Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. J Vasc Interv Radiol 2014; 25: 365-369
• 3 Ramsey DE, Kernagis LY, Soulen MC et al. Chemoembolization of Hepatocellular Carcinoma. JVIR 2002; 1w3: 211-221
• 4 Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of Hepatozellular Carcinoma. Semin Intervent Radiol 2013; 30: 3-11
• 5 Lencioni R, Llovet JM, Han G. Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial. J Clin Oncol 2012; 30 (Suppl. 04) abstr LBA154^